Roughly 20% of medical schools now offer an accelerated pathway meant to reduce student debt and somehow fix the primary care ...

For the first nine months of 2024, The LVS Growth Portfolio gained 27.1% and the LVS Event-Driven Portfolio gained 4.9%, net ...

Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company ...

UCSF Health is opening retail pharmacies at its Mission Bay and Parnassus campuses. The new pharmacies build on UCSF Health’s ...

The clinical research program at Intermountain Health's St. Vincent Regional Hospital has come a long way since its inception ...

Up to 15% of adults in the United States hear a constant companion: tinnitus. This medical condition manifests as an ...

Through project PROTECT, a new method for dosing could support individuals suffering from cystic fibrosis ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

More than 8 million people, ages 40 and older, living in the U.S. are affected by peripheral arterial disease, a lifelong medical condition and the most common cause of limb amputation in the country.

Reprogrammed stem cells are being tested in at least 50 clinical trials around the globe, and the first approved therapy ...

New study shows that the lengths of menstrual cycles, follicular phases (before egg release) and luteal phases (after ovulation) are all variable. The luteal phase is importantly more variable than ...

More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the ...